Assentus Biogenics Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 5.95 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.01 Cr
- Revenue Growth 113.21%
- Profit Growth 337.87%
- Ebitda 136.47%
- Net Worth 144.72%
- Total Assets -9.93%
About Assentus Biogenics
Assentus Biogenics Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2013 and has a history of 11 years and seven months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 5.95 M.
The company currently has active open charges totaling ₹1.01 Cr.
Soumyen Basak, Debasis Chakrabarti, and Kabita Basak serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100WB2013PTC195114
-
Company No.
195114
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Jun 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Assentus Biogenics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debasis Chakrabarti
|
Director | 30-Sep-2023 | Current |
|
Soumyen Basak
|
Director | 01-Apr-2015 | Current |
|
Kabita Basak
|
Additional Director | 27-Feb-2021 | Current |
Financial Performance of Assentus Biogenics.
Assentus Biogenics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 113.21% increase. The company also saw a substantial improvement in profitability, with a 337.87% increase in profit. The company's net worth Soared by an impressive increase of 144.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assentus Biogenics?
In 2023, Assentus Biogenics had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hunteyed Tech Private LimitedSoumyen Basak is a mutual person
-
Trikem Remedies Llp
Kabita Basak is a mutual person
Charges (Loans)
₹10.08 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.01 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2024 | Others | ₹5.00 M | Open |
| 22 Oct 2020 | Others | ₹0.80 M | Open |
| 09 Sep 2020 | Others | ₹0.28 M | Open |
| 20 Dec 2017 | Others | ₹4.00 M | Open |
How Many Employees Work at Assentus Biogenics?
Assentus Biogenics has a workforce of 15 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assentus Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assentus Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
